Breakthrough treatments for lung cancer and melanoma have driven down cancer deaths, seeing the largest ever decline from 2016 to 2017.
Collaboration within the healthcare industry is needed to push the cancer death rate down.
Cancer treatment is becoming more personalized. Here’s how.
Because the disease in males is rare, they have historically been excluded from clinical trials of breast cancer drugs.
From breast cancer to prostate cancer, the state of oncology care and how it will evolve.
Customized survivorship plans specific to the cancer the patient endured and the treatment they received are essential.
Oncologists are under intense pressure to come up with cost savings—and many are turning to value-based care structures.
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
A new NIH report on cancer in people aged 20 to 49 shows that while rates are declining, women and minorities still face significant rates.
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.